Trials / Conditions / Bardet Biedl Syndrome (BBS)
Bardet Biedl Syndrome (BBS)
3 registered clinical trials studyying Bardet Biedl Syndrome (BBS) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Bardet Beidle Syndrome in a Syrian Adolescent : a Rare Case Report NCT06615011 | Al Baath University | — |
| Completed | Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syn NCT03746522 | Rhythm Pharmaceuticals, Inc. | Phase 3 |
| Approved For Marketing | An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS) NCT05183802 | Rhythm Pharmaceuticals, Inc. | — |